These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20981155)

  • 1. Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment.
    Montes-Moreno S
    Adv Hematol; 2011; 2011():142395. PubMed ID: 20981155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
    Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
    Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
    Wu D; Thomas A; Fromm JR
    Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells.
    Seliem RM; Ferry JA; Hasserjian RP; Harris NL; Zukerberg LR
    J Hematop; 2011 Sep; 4(3):175. PubMed ID: 32288859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of Hodgkin's lymphoma.
    Eberle FC; Mani H; Jaffe ES
    Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and differential diagnosis of nodular lymphocyte-predominant Hodgkin's lymphoma.
    Liu Y; Zhu X; Zhuang H; Lin H; Wu Q; Jiang G; Gu Y; Luo D; Luo X
    Zhonghua Bing Li Xue Za Zhi; 2002 Jun; 31(3):227-30. PubMed ID: 12475440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.
    van Grotel M; Lam KH; de Man R; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
    Leuk Lymphoma; 2006 Aug; 47(8):1504-10. PubMed ID: 16966260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on the Pathology and Molecular Features of Hodgkin Lymphoma.
    Satou A; Takahara T; Nakamura S
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics.
    Younes S; Rojansky RB; Menke JR; Gratzinger D; Natkunam Y
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's lymphomas: classification, diagnosis, and grading.
    Harris NL
    Semin Hematol; 1999 Jul; 36(3):220-32. PubMed ID: 10462322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular lymphocyte predominant Hodgkin's lymphoma.
    Siddiqui N; Al-Diab AI
    Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathological diagnosis of Hodgkin lymphoma].
    Tamaru J
    Nihon Rinsho; 2014 Mar; 72(3):450-5. PubMed ID: 24724402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
    Tian X; Xu J; Dorfman DM
    Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres.
    Illés A; Simon Z; Tóth E; Rosta A; Miltényi Z; Molnár Z
    Pathol Oncol Res; 2008 Dec; 14(4):411-21. PubMed ID: 18431694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimising chemotherapy while optimising immune therapy for paediatric nodular lymphocyte-predominant Hodgkin's lymphoma.
    Farhan R; Alqarni NS; Algiraigri AH
    J Taibah Univ Med Sci; 2020 Dec; 15(6):554-556. PubMed ID: 33318747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular Lymphocyte Predominant Hodgkin Lymphoma With Aberrant Immunophenotype or Variant Histopathology: Insights From Case Series of Three Patients.
    Chander G; Dassanayake H; Kaparou M; Ahmed M; Kishore B; Nikolousis E; Kanellopoulos A
    Anticancer Res; 2021 Aug; 41(8):4017-4020. PubMed ID: 34281867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Extranodal Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Thyroid.
    Williams TP; Raess PW; Braziel R; Cascio MJ
    Head Neck Pathol; 2020 Jun; 14(2):550-553. PubMed ID: 31292857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.
    Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S
    Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.